Valerie Morisset - 01 Jul 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Signature
/s/ William Cowles, Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
01 Jul 2024
Net transactions value
-$337,998
Form type
4
Filing time
03 Jul 2024, 14:42:03 UTC
Previous filing
08 Apr 2024
Next filing
09 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELYM Common Stock Options Exercise $1.53 +7,649 +1.5% $0.000200* 512,956 01 Jul 2024 Direct
transaction ELYM Common Stock Sale $338,000 -50,000 -9.7% $6.76 462,956 03 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right to Buy) Options Exercise $0 -7,649 -43% $0.000000 10,198 01 Jul 2024 Common Stock 7,649 $0.000200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48thof the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021Vesting Commencement Date.